Klotho  ||| S:0 E:7 ||| NNP
and  ||| S:7 E:11 ||| CC
kidney  ||| S:11 E:18 ||| NN
disease  ||| S:18 E:26 ||| NN
Klotho  ||| S:26 E:33 ||| NNP
is  ||| S:33 E:36 ||| VBZ
a  ||| S:36 E:38 ||| DT
single-pass  ||| S:38 E:50 ||| JJ
transmembrane  ||| S:50 E:64 ||| JJ
protein  ||| S:64 E:72 ||| NN
that  ||| S:72 E:77 ||| IN
exerts  ||| S:77 E:84 ||| VBG
its  ||| S:84 E:88 ||| PRP$
biological  ||| S:88 E:99 ||| JJ
functions  ||| S:99 E:109 ||| NNS
through  ||| S:109 E:117 ||| IN
multiple  ||| S:117 E:126 ||| JJ
modes ||| S:126 E:131 ||| NNS
.  ||| S:131 E:133 ||| .
Membrane-bound  ||| S:133 E:148 ||| NNP
Klotho  ||| S:148 E:155 ||| NNP
acts  ||| S:155 E:160 ||| VBZ
as  ||| S:160 E:163 ||| RB
coreceptor  ||| S:163 E:174 ||| VBN
for  ||| S:174 E:178 ||| IN
the  ||| S:178 E:182 ||| DT
major  ||| S:182 E:188 ||| JJ
phosphatonin  ||| S:188 E:201 ||| JJ
fibroblast  ||| S:201 E:212 ||| JJ
growth  ||| S:212 E:219 ||| NN
factor-23  ||| S:219 E:229 ||| NNP
( ||| S:229 E:230 ||| -LRB-
FGF23 ||| S:230 E:235 ||| NNP
) ||| S:235 E:236 ||| -RRB-
,  ||| S:236 E:238 ||| ,
while  ||| S:238 E:244 ||| IN
soluble  ||| S:244 E:252 ||| JJ
Klotho  ||| S:252 E:259 ||| JJ
functions  ||| S:259 E:269 ||| NNS
as  ||| S:269 E:272 ||| IN
an  ||| S:272 E:275 ||| DT
endocrine  ||| S:275 E:285 ||| JJ
substance ||| S:285 E:294 ||| NN
.  ||| S:294 E:296 ||| .
In  ||| S:296 E:299 ||| IN
addition  ||| S:299 E:308 ||| NN
to  ||| S:308 E:311 ||| TO
in  ||| S:311 E:314 ||| IN
the  ||| S:314 E:318 ||| DT
distal  ||| S:318 E:325 ||| JJ
nephron  ||| S:325 E:333 ||| NN
where  ||| S:333 E:339 ||| WRB
it  ||| S:339 E:342 ||| PRP
is  ||| S:342 E:345 ||| VBZ
abundantly  ||| S:345 E:356 ||| RB
expressed ||| S:356 E:365 ||| VBN
,  ||| S:365 E:367 ||| ,
Klotho  ||| S:367 E:374 ||| NNP
is  ||| S:374 E:377 ||| VBZ
present  ||| S:377 E:385 ||| JJ
in  ||| S:385 E:388 ||| IN
the  ||| S:388 E:392 ||| DT
proximal  ||| S:392 E:401 ||| JJ
tubule  ||| S:401 E:408 ||| JJ
lumen  ||| S:408 E:414 ||| NN
where  ||| S:414 E:420 ||| WRB
it  ||| S:420 E:423 ||| PRP
inhibits  ||| S:423 E:432 ||| FW
renal  ||| S:432 E:438 ||| FW
Pi  ||| S:438 E:441 ||| FW
excretion  ||| S:441 E:451 ||| FW
by  ||| S:451 E:454 ||| FW
modulating  ||| S:454 E:465 ||| FW
Na-coupled  ||| S:465 E:476 ||| FW
Pi  ||| S:476 E:479 ||| FW
transporters  ||| S:479 E:492 ||| FW
via  ||| S:492 E:496 ||| FW
enzymatic  ||| S:496 E:506 ||| FW
glycan  ||| S:506 E:513 ||| FW
modification  ||| S:513 E:526 ||| NN
of  ||| S:526 E:529 ||| IN
the  ||| S:529 E:533 ||| DT
transporter  ||| S:533 E:545 ||| JJ
proteins  ||| S:545 E:554 ||| NNS
-  ||| S:554 E:556 ||| :
an  ||| S:556 E:559 ||| DT
effect  ||| S:559 E:566 ||| NN
completely  ||| S:566 E:577 ||| RB
independent  ||| S:577 E:589 ||| JJ
of  ||| S:589 E:592 ||| IN
its  ||| S:592 E:596 ||| PRP$
role  ||| S:596 E:601 ||| NN
as  ||| S:601 E:604 ||| IN
the  ||| S:604 E:608 ||| DT
FGF23  ||| S:608 E:614 ||| JJ
coreceptor ||| S:614 E:624 ||| NN
.  ||| S:624 E:626 ||| .
Acute  ||| S:626 E:632 ||| JJ
kidney  ||| S:632 E:639 ||| NN
injury  ||| S:639 E:646 ||| NN
( ||| S:646 E:647 ||| -LRB-
AKI ||| S:647 E:650 ||| NNP
)  ||| S:650 E:652 ||| -RRB-
and  ||| S:652 E:656 ||| CC
chronic  ||| S:656 E:664 ||| JJ
kidney  ||| S:664 E:671 ||| NN
disease  ||| S:671 E:679 ||| NN
( ||| S:679 E:680 ||| -LRB-
CKD ||| S:680 E:683 ||| NNP
)  ||| S:683 E:685 ||| -RRB-
are  ||| S:685 E:689 ||| VBP
states  ||| S:689 E:696 ||| NNS
of  ||| S:696 E:699 ||| IN
systemic  ||| S:699 E:708 ||| JJ
Klotho  ||| S:708 E:715 ||| JJ
deficiency ||| S:715 E:725 ||| NN
,  ||| S:725 E:727 ||| ,
making  ||| S:727 E:734 ||| VBG
Klotho  ||| S:734 E:741 ||| NNP
a  ||| S:741 E:743 ||| DT
very  ||| S:743 E:748 ||| RB
sensitive  ||| S:748 E:758 ||| JJ
biomarker  ||| S:758 E:768 ||| NN
of  ||| S:768 E:771 ||| IN
impaired  ||| S:771 E:780 ||| JJ
renal  ||| S:780 E:786 ||| JJ
function ||| S:786 E:794 ||| NN
.  ||| S:794 E:796 ||| .
In  ||| S:796 E:799 ||| IN
addition  ||| S:799 E:808 ||| NN
to  ||| S:808 E:811 ||| TO
its  ||| S:811 E:815 ||| PRP$
role  ||| S:815 E:820 ||| NN
as  ||| S:820 E:823 ||| IN
a  ||| S:823 E:825 ||| DT
marker ||| S:825 E:831 ||| NN
,  ||| S:831 E:833 ||| ,
Klotho  ||| S:833 E:840 ||| NNP
also  ||| S:840 E:845 ||| RB
plays  ||| S:845 E:851 ||| VBZ
pathogenic  ||| S:851 E:862 ||| JJ
roles  ||| S:862 E:868 ||| NNS
in  ||| S:868 E:871 ||| IN
renal  ||| S:871 E:877 ||| JJ
disease ||| S:877 E:884 ||| NN
.  ||| S:884 E:886 ||| .
Klotho  ||| S:886 E:893 ||| JJ
deficiency  ||| S:893 E:904 ||| NN
exacerbates  ||| S:904 E:916 ||| VBZ
decreases  ||| S:916 E:926 ||| VBN
in ||| S:926 E:928 ||| IN
,  ||| S:928 E:930 ||| ,
while  ||| S:930 E:936 ||| IN
Klotho  ||| S:936 E:943 ||| NNP
repletion  ||| S:943 E:953 ||| NN
or  ||| S:953 E:956 ||| CC
excess  ||| S:956 E:963 ||| JJ
preserves ||| S:963 E:972 ||| NN
,  ||| S:972 E:974 ||| ,
glomerular  ||| S:974 E:985 ||| JJ
filtration  ||| S:985 E:996 ||| JJ
rate  ||| S:996 E:1001 ||| NN
in  ||| S:1001 E:1004 ||| IN
both  ||| S:1004 E:1009 ||| DT
AKI  ||| S:1009 E:1013 ||| NNP
and  ||| S:1013 E:1017 ||| CC
CKD ||| S:1017 E:1020 ||| NNP
.  ||| S:1020 E:1022 ||| .
Soft  ||| S:1022 E:1027 ||| JJ
tissue  ||| S:1027 E:1034 ||| NN
calcification ||| S:1034 E:1047 ||| NN
,  ||| S:1047 E:1049 ||| ,
and  ||| S:1049 E:1053 ||| CC
especially  ||| S:1053 E:1064 ||| RB
vascular  ||| S:1064 E:1073 ||| JJ
calcification ||| S:1073 E:1086 ||| NN
,  ||| S:1086 E:1088 ||| ,
is  ||| S:1088 E:1091 ||| VBZ
a  ||| S:1091 E:1093 ||| DT
dire  ||| S:1093 E:1098 ||| JJ
complication  ||| S:1098 E:1111 ||| NN
in  ||| S:1111 E:1114 ||| IN
CKD ||| S:1114 E:1117 ||| NNP
,  ||| S:1117 E:1119 ||| ,
associated  ||| S:1119 E:1130 ||| VBN
with  ||| S:1130 E:1135 ||| IN
high  ||| S:1135 E:1140 ||| JJ
mortality ||| S:1140 E:1149 ||| NN
.  ||| S:1149 E:1151 ||| .
Klotho  ||| S:1151 E:1158 ||| NNP
protects  ||| S:1158 E:1167 ||| VBZ
against  ||| S:1167 E:1175 ||| IN
soft  ||| S:1175 E:1180 ||| JJ
tissue  ||| S:1180 E:1187 ||| NN
calcification  ||| S:1187 E:1201 ||| NN
via  ||| S:1201 E:1205 ||| IN
at  ||| S:1205 E:1208 ||| IN
least  ||| S:1208 E:1214 ||| JJS
3  ||| S:1214 E:1216 ||| CD
mechanisms ||| S:1216 E:1226 ||| NNS
:  ||| S:1226 E:1228 ||| :
phosphaturia ||| S:1228 E:1240 ||| CD
,  ||| S:1240 E:1242 ||| ,
preservation  ||| S:1242 E:1255 ||| NN
of  ||| S:1255 E:1258 ||| IN
renal  ||| S:1258 E:1264 ||| JJ
function  ||| S:1264 E:1273 ||| NN
and  ||| S:1273 E:1277 ||| CC
a  ||| S:1277 E:1279 ||| DT
direct  ||| S:1279 E:1286 ||| JJ
effect  ||| S:1286 E:1293 ||| NN
on  ||| S:1293 E:1296 ||| IN
vascular  ||| S:1296 E:1305 ||| JJ
smooth  ||| S:1305 E:1312 ||| JJ
muscle  ||| S:1312 E:1319 ||| NN
cells  ||| S:1319 E:1325 ||| NNS
by  ||| S:1325 E:1328 ||| IN
inhibiting  ||| S:1328 E:1339 ||| JJ
phosphate  ||| S:1339 E:1349 ||| JJ
uptake  ||| S:1349 E:1356 ||| NN
and  ||| S:1356 E:1360 ||| CC
dedifferentiation ||| S:1360 E:1377 ||| NN
.  ||| S:1377 E:1379 ||| .
In  ||| S:1379 E:1382 ||| IN
summary ||| S:1382 E:1389 ||| NN
,  ||| S:1389 E:1391 ||| ,
Klotho  ||| S:1391 E:1398 ||| NNP
is  ||| S:1398 E:1401 ||| VBZ
a  ||| S:1401 E:1403 ||| DT
critical  ||| S:1403 E:1412 ||| JJ
molecule  ||| S:1412 E:1421 ||| NN
in  ||| S:1421 E:1424 ||| IN
a  ||| S:1424 E:1426 ||| DT
wide  ||| S:1426 E:1431 ||| JJ
variety  ||| S:1431 E:1439 ||| NN
of  ||| S:1439 E:1442 ||| IN
renal  ||| S:1442 E:1448 ||| JJ
diseases  ||| S:1448 E:1457 ||| NNS
and  ||| S:1457 E:1461 ||| CC
bears  ||| S:1461 E:1467 ||| VBZ
great  ||| S:1467 E:1473 ||| JJ
potential  ||| S:1473 E:1483 ||| NN
as  ||| S:1483 E:1486 ||| IN
a  ||| S:1486 E:1488 ||| DT
diagnostic  ||| S:1488 E:1499 ||| JJ
and  ||| S:1499 E:1503 ||| CC
prognostic  ||| S:1503 E:1514 ||| JJ
biomarker  ||| S:1514 E:1524 ||| NN
as  ||| S:1524 E:1527 ||| IN
well  ||| S:1527 E:1532 ||| RB
as  ||| S:1532 E:1535 ||| RB
for  ||| S:1535 E:1539 ||| IN
therapeutic  ||| S:1539 E:1551 ||| JJ
replacement  ||| S:1551 E:1563 ||| NN
therapy ||| S:1563 E:1570 ||| NN
.  ||| S:1570 E:1572 ||| .
